2021 Asian Pacific Society of Cardiology Consensus Recommendations on the use of P2Y12 receptor antagonists in the Asia-Pacific Region: Special populations.

W E I C H I E H T A N Tan; P C H E W Chew; L A M T S U I Tsui; T A N Tan; D U P L Y A K O V Duplyakov; H A M M O U D E H Hammoudeh; Bo Zhang; Yi LI; Kai XU; J O N G Ong; Doni Firman; G A M R A Gamra; A L M A H M E E D Almahmeed; D A L A L Dalal; T A N Tan; S T E G Steg; N N G U Y E N Nguyen; A K O Ako; A L S U W A I D I Suwaidi; C H A N Chan; S O B H Y Sobhy; S H E H A B Shehab; B U D D H A R I Buddhari; Zu Lv Wang; Y E A N Y I P F O N G Fong; K A R A D A G Karadag; K I M Kim; B A B E R Baber; T A N G C H I N Chin; Ya Ling Han

Return

2021 Asian Pacific Society of Cardiology Consensus Recommendations on the use of P2Y12 receptor antagonists in the Asia-Pacific Region: Special populations.

Author: W E I C H I E H T A N TAN ¹ ; P C H E W CHEW ² ; L A M T S U I TSUI ³ ; T A N TAN ⁴ ; D U P L Y A K O V DUPLYAKOV ⁵ ; H A M M O U D E H HAMMOUDEH ⁶ ; Bo ZHANG ⁷ ; Yi LI ⁸ ; Kai XU ⁸ ; J O N G ONG ⁹ ; Doni FIRMAN ¹⁰ ; G A M R A GAMRA ¹¹ ; A L M A H M E E D ALMAHMEED ¹² ; D A L A L DALAL ¹³ ; T A N TAN ¹⁴ ; S T E G STEG ¹⁵ ; N N G U Y E N NGUYEN ¹⁶ ; A K O AKO ¹⁷ ; A L S U W A I D I SUWAIDI ¹⁸ ; C H A N CHAN ¹⁹ ; S O B H Y SOBHY ²⁰ ; S H E H A B SHEHAB ²¹ ; B U D D H A R I BUDDHARI ²² ; Zu Lv WANG ⁸ ; Y E A N Y I P F O N G FONG ²³ ; K A R A D A G KARADAG ²⁴ ; K I M KIM ²⁵ ; B A B E R BABER ²⁶ ; T A N G C H I N CHIN ²⁷ ; Ya Ling HAN ⁸
Author Information

1. National Heart Centre, Singapore Sengkang General Hospital, Singapore.
2. College of Medicine and Public Health, Flinders University, Adelaide, Australia.
3. Pamela Youde Nethersole Eastern Hospital, Hong Kong, China.
4. Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore.
5. Samara Regional Cardiology Dispensary, Samara, Russia.
6. Cardiology Department, Istishari Hospital, Amman, Jordan.
7. Department of Cardiology, First Affiliated Hospital, Dalian Medical University, Dalian 116000, China.
8. Department of Cardiology, General Hospital of Northern Theatre Command, Shenyang 110840, China.
9. Heart Specialist International, Mount Elizabeth Novena Hospital, Singapore Tan Tock Seng Hospital, Singapore.
10. Harapan Kita National Cardiovascular Center/Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia Harapan Kita, Jakarta, Indonesia.
11. Cardiology Department, Fattouma Bourguiba University Hospital and University of Monastir, Monastir, Tunisia.
12. Cleveland Clinic Abu Dhabi, United Arab Emirates.
13. Centre for Cardiac Sciences, Kokilaben Dhirubhai Ambani Hospital, Mumbai, India.
14. Kwong Wah Hospital, Hong Kong, China.
15. Department of Cardiology, Hôpital Bichat, Paris, France.
16. Department of Cardiology, Hanoi Medical University, Hanoi, Vietnam.
17. Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.
18. Adult Cardiology, Hamad Medical Corporation, Doha, Qatar.
19. National University Heart Centre, Singapore.
20. Faculty of Medicine, Alexandria University, Egypt.
21. College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates.
22. King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
23. Sarawak Heart Centre, Kota Samarahan, Malaysia.
24. Istanbul University Cerrahpasa School of Medicine, Istanbul, Turkey.
25. Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea.
26. University of Oklahoma Health Sciences Center, Oklahoma City, OK, US.
27. National Heart Centre, Singapore.
Publication Type:Journal Article
MeSH: Purinergic P2Y Receptor Antagonists; Consensus; Cardiovascular System; Cardiology; Asia
From: Chinese Journal of Cardiology 2023;51(1):19-31
CountryChina
Language:Chinese